MOORE JOHN R Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
32
Insider Sells Sum
$4.82M

Insider Activity of MOORE JOHN R

According to the SEC Form 4 filings, MOORE JOHN R, being in a position of

  1. General Counsel at Edgewise Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5016 shares for $219,823,
    over all time since 2022-05-16, has bought 0 shares, and sold 256908 shares for $3.99M.

Biography of MOORE JOHN R

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $219,8231100

Comparison of Insiders on Amount of Buys and Sells

2026-08-12SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
5,016
0.0047%
$43.82$219,823-5.23%
2025-08-12SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
2,098
0.0021%
$13.39$28,097+118.37%
2025-05-02SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
1,930
0.0018%
$16.45$31,757+1.27%
2024-09-23SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
20,922
0.0233%
$27.63$578,064-11.97%
2024-09-20SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
50,000
0.0535%
$28.37$1.42M-17.11%
2024-05-02SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
1,956
0.0021%
$18.91$36,988+22.94%
2024-02-09SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
8,029
0.0109%
$20.01$160,657-2.05%
2024-02-08SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
3,813
0.0052%
$20.01$76,285-3.18%
2024-02-07SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
17,993
0.0245%
$20.00$359,864-3.41%
2023-12-27SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
8,497
0.0116%
$10.50$89,219+49.96%
2023-05-02SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
1,897
0.0031%
$8.90$16,893-7.66%
2022-10-03SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
4,730
0.0089%
$9.76$46,155-12.04%
2022-09-06SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
2,351
0.0048%
$10.99$25,842-13.63%
2022-08-03SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
9,232
0.018%
$9.31$85,921+2.5%
2022-07-05SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
8,186
0.0154%
$8.35$68,329+12.16%
2022-06-16SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
31,078
0.0731%
$7.29$226,695+53.44%
2022-06-13SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
18,075
0.0371%
$6.11$110,445+59.83%
2022-06-08SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
7,125
0.013%
$6.05$43,120+43.84%
2022-06-03SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
32,380
0.0678%
$6.35$205,474+56.55%
2022-05-16SaleEdgewise Therapeutics, Inc.
EWTX
General Counsel
21,600
0.0443%
$7.42$160,291+29.49%
Total: 35
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.